High-throughput sequencing of RNAs isolated by cross-linking immunoprecipitation (HITS-CLIP) reveals Argonaute-associated microRNAs and targets in Schistosoma japonicum by Jing Zhao et al.
RESEARCH Open Access
High-throughput sequencing of RNAs
isolated by cross-linking immunoprecipitation
(HITS-CLIP) reveals Argonaute-associated
microRNAs and targets in Schistosoma japonicum
Jing Zhao1, Rong Luo1, Xindong Xu1, Ying Zou1, Qingfeng Zhang1* and Weiqing Pan1,2*
Abstract
Background: Schistosomiasis, caused by schistosomes, is one of the most prevalent and serious parasitic diseases in
tropical and subtropical countries. This pathogen has a complex life cycle and harbors a unique repertoire of genes
expressed at different life-stages. Understanding the gene regulation of schistosomes will contribute to identification
of novel drug targets and vaccine candidates. Some conserved and novel microRNAs (miRNAs) have been
identified in schistosomes as key transcriptional and post-transcriptional regulators in the past few years; however,
little is known about their specific targets.
Methods: High-throughput sequencing of RNAs isolated by cross-linking immunoprecipitation (HITS-CLIP) was used
to covalently crosslink native Argonaute protein-RNA complexes in Schistosoma japonicum. An antibody against
S.japonicum Argonaute proteins, was generated and used for immunoprecipitation of the crosslinked SjAgo-RNA
complex from soluble adult worm extract. Small RNAs, including miRNAs and their target mRNAs associated with
the native SjAgo in adult parasites, were enriched and extracted for library construction.
Results: High-throughput sequencing produced a total of ~7.4 million high-quality reads, of which approximately
45.07 % were composed of 769 miRNAs and 35.54 % were composed of 11,854 mRNAs target sites. Further
bioinformatics analysis identified 43 conserved known miRNAs and 256 novel miRNAs in the SjAgo-associated small
RNA population. An average of approximately 15 target sites were predicted for each miRNA. Moreover, a positive
rate of 50 % has been achieved in a small-scale verification test of the putative target sites of miRNA1.
Conclusion: In this study, we isolated and identified small RNAs including miRNAs and their targets associated with
the S. japonicum Argonaute proteins, by the HITS-CLIP method combined with bioinformatics and biologic
experimental analysis. These data reveal a genome-wide miRNA-mRNA interaction map in S. japonicum in vivo,
which will help us understand the complex gene regulatory network in this pathogen and thereby facilitate the
development of novel drug approaches against schistosomiasis.
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Background
Human schistosomiasis is one of the most prevalent and
serious parasitic diseases in tropical and subtropical re-
gions [1]. It affected approximately 200 million people
worldwide. In China, this infectious disease caused by
Schistosoma japonicum remains a major public health
problem [2, 3]. Schistosome parasite undergoes a com-
plex life cycle involving multiple development stages, in-
cluding egg, miracidium, cercaria, schistosomulum, and
adult worm. Each stage may be controlled by various
gene regulation mechanisms, which are crucial for devel-
opment, infection, immune evasion, and pathogenesis of
the blood flukes [4]. To date, the genomes of three
major pathogenic schistosome species, including that of
S. japonicum, have been published. However, current un-
derstanding of the regulatory mechanisms of stage-
specific gene expression is still limited [4–7].
In recent years, microRNAs (miRNAs) have received
huge attention as key regulators of gene expression both
at transcriptional and post-transcriptional levels in vari-
ous organisms [8–14]. miRNAs belong to a class of
small non-coding RNAs (18–25 nt) generated from en-
dogenous transcripts with hairpin structures [15–19].
Dicer and Argonaute (Ago) are the two core proteins in-
volved in this pathway [20–22]. Primary transcripts of
miRNA (pri-miRNA) are transcribed by RNA polymer-
ase II and processed by RNase III in the nucleus. An-
other RNase III enzyme, Dicer, reprocesses the pri-
miRNAs into precursor miRNAs (pre-miRNA). Pre-
miRNAs were subsequently transported from nucleus to
cytoplasm, where they are sheared into mature miRNA
by Dicer. miRNAs bind to the RNA-induced silencing
complex (RISC), which contains the Argonaute protein.
miRNAs are targeted to the single-stranded complemen-
tary mRNA [15, 19, 22]. Recent studies suggested an
Ago–miRNA–mRNA ternary complex could be formed,
and the technique of high-throughput sequencing of
RNAs isolated by crosslinking immunoprecipitation
(HITS-CLIP) [23] may allow us to identify the
Argonaute-associated miRNAs and their target sites
simultaneously.
In schistosomes, the emerging evidence for the exist-
ence of miRNAs hinted at the existence of miRNA-
mediated gene regulation pathway critical for the gene
expression [24–29]. To date, by the conventional poly-
acrylamide gel electrophoresis (PAGE) enrichment [28],
only about 60 miRNAs have been identified for the
Schistosoma genus, including about 55 in S. japonicum,
and little is known of their target sites or biological func-
tions [24, 25]. To this end, we aim to systematically
analyze the miRNA repertoire and the potential target
mRNAs by adapting HITS-CLIP assay [23] in S.japoni-
cum with an antibody specific to Argonaute proteins,
the core component of RISC complex [30]. Using
bioinformatics and molecular biological analysis, re-
searchers have identified and characterized four putative
S. japonicum Argonaute (SjAgo) orthologues [31]. While
the SjAgo2 has been demonstrated to function in main-
tenance of genome stability via suppression of retrotran-
sposons [26], SjAgo has been speculated to be involved
in the miRNA pathway due to its highly conserved func-
tional PIWI and PAZ domains [30]. There are, however,
no experimental data available yet.
In the present study, we generated a specific antibody
to SjAgo proteins for immunoprecipitation of SjAgo-
miRNA-mRNA ternary complex [23]. After enrichment
and extraction of the small RNAs associated with the
native SjAgo, deep sequencing was carried out on the
resulting cDNA library. A total of approximately 7.4 mil-
lion high-quality reads were produced, and approxi-
mately 45.07 % of the reads were composed of miRNAs
and 35.54 % were mRNAs. Further bioinformatics ana-
lysis identified 43 known miRNAs and 256 novel miR-
NAs in the SjAgo-associated small RNA population. An
average of approximately 15 target sites were predicted
for each miRNA. Moreover, partial target sites of




Animal experiments were performed in accordance with
the National Guidelines for the Use and Care of Labora-
tory Animals, and the study was approved by the Institu-
tional Animal Care and Use Committee of Tongji
University.
Parasites and animals
The S. japonicum strain used in this study was obtained
from Anhui province of China and was maintained in
Oncomelania hupensis snails for laboratory studies in
China. No permission was required to use parasites from
this location in the study. Furthermore, our study did
not involve the use of endangered or protected species.
To collect S.japonicum worms (7d, 14d, 21d, 28d, 35d,
and 42d) and eggs, a total of 50 BALB/C mice were in-
fected percutaneously with cercariae of S. japonicum (40
worms/mouse) shed from naturally infected snails. No
mice died until they were sacrificed for parasite collec-
tion. Then, the worms and eggs were collected at desired
time points from the mesenteric veins and the livers of
the infected mice which were sacrificed by cervical dis-
location [24].
Construction of recombination plasmid
For constructing the recombinant plasmid pET28a
(+)-Ago1-Piwi, total RNA of S.japonicum was isolated
from 28 d adult worms using TRIzol reagent (Invitrogen,
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USA) and treated with RNase-free DNase. Then, 0.5 μg
of total RNA was used as template for the prepar-
ation of cDNA [28]. The segment (958 bp) of SjAgo1
gene was amplified by primers SjAgo1-Piwi-F 5’gccg
ccatgggatgttcgtttttactacttattct 3’ and SjAgo1-Piwi-R 5’g
cgcggatcctcattagtggtgatggtgatggtgaaacatcccatcgacctgcga
cata 3’ and was cloned into the expression vector
pET28a (+) at a multiple cloning site (BamHI and NcoI).
For protein purification, the coding sequence of six tan-
dem His-tag (His x 6) was fused to the C-terminus of the
target sequence [32]. Finally, the cloned sequence was
verified using sequencing analysis.
Expression and purification of the recombinant protein
pET28a (+)-Ago1-Piwi plasmid was transfected into
competent BL21 bacteria, and expression of the recom-
binant protein was induced by 0.1 mM IPTG at 37 °C
for 6 h. Protein purification was performed using E.coli
lysate under denaturing conditions according to the
manufacturer’s instructions (Cat: 706663, Novagen). The
purity and concentration of the recombinant protein
were determined by polyacrylamide gel electrophoresis
(PAGE) and Lowry method.
Preparation of antiserum against SjAgo
Antibodies against recombinant SjAgo were stimulated
in New Zealand white rabbits by repeated immuniza-
tions. 0.5 mg recombinant protein was briefly emulsified
with isopyknic Freund’s complete adjuvant and injected
into rabbits subcutaneously. Two booster injections were
administered with 500 μg recombinant SjAgo1 in incom-
plete Freund’s adjuvant at 2-week intervals. Ten days
after the final injection, 50 ml of blood was collected
and kept overnight at room temperature to allow for
clotting of the blood. The crude antiserum was collected
by centrifugation at 1500 g for 10 min. The titer and
specificity of the antiserum were determined by ELISA
and western blotting, respectively.
Western blotting
Protein samples were mixed with equal volume of 2 ×
SDS-PAGE loading buffer and boiled at 100 °C for
5 min, then immediately kept it on ice for 10 min. After
that protein samples were separated by 10 % SDS-PAGE
and transferred to PVDF membrane. Next, the mem-
brane was blocked in 5 % non-fat milk in PBST for 2 h
at room temperature. The membrane was then incu-
bated with primary antibody solution (1:2000) for 12 h
at 4 °C, followed by reaction with secondary antibody
conjugated with HRP for 1 h at room temperature [33].
Finally, the membrane was developed by ECL substrate
and detected by GE ImageQuant LAS 4000.
HITS-CLIP
1) Cell lysate. S. japonicum fresh adult worms
(~200 mg) were washed 3 times by pre-chilled
1xPBS (pH7.4). To collect single cells, the worms
were transferred to a 100 mesh metal sieve and
grinded gently with mortar. The cells were sus-
pended with 10 ml pre-chilled 1xPBS
(pH 7.4),transferred into a sterile dish with 1 mm
depth, and UV-crosslinked using the dose,
400 mJ/cm2 for 30 sec each time, twice. After
that, the cells were collected by centrifugation at
3000 rpm for 10 min at 4 °C. 700 μl PXL (1xPBS,
0.1 % SDS, 0.5 % deoxycholate, 0.5 % NP-40),
protein inhibitors and 15 μl RNasin (Promega)
were added and mixed with 1 ml pipette. The
mixture was incubated for 10 min on ice. Next,
10 μl RNase (40 U/μl ) was added and incubated
for 5 min at 37 °C. Finally, the cell lysate was
centrifuged at 14,000 rpm at 4 °C for 20 min, and
the supernatant was transferred to a new tube.
The cell lysate was stored at −80 °C for co-
immunoprecipitation experiment.
2) Pretreatment of protein A agarose bead. Two
milliliters of 0.1 M 1xPBS (pH 8.0) were used to
wash protein A agarose bead (800 μl) followed by
centrifugation at 2000 rpm at 4 °C for 5 min. This
step was repeated twice and the protein A-agarose
were resuspended by 800 μl of 0.1 M 1x PBS
(pH 8.0) and divided into two tubes equally. While
50 μl normal serum control was added to tube 1,
50 μl anti-SjAgo serum was added to tube 2. Both
tube 1 and 2 were incubated at 4 °C for 4 h. After
that, the protein A-agarose was collected by centri-
fugation for 5 min at 2000 rpm at 4 °C.
3) Co-Immunoprecipitation. 1 ml total protein
extracted in step 1 was used to resuspend the
pretreated protein A-agarose, and the mixture was
incubated at 4 °C for 4 h at 100 rpm on a rotator.
Then, the protein A-agarose was collected by
centrifugation for 5 min at 2000 rpm at 4 °C. The
supernatant was discarded and the beads were
washed 6 times with 1 × PKL buffer. After washing,
200 μl PNK Buffer (50 mM Tris-Cl pH 7.4, 10 mM
MgCl2, 0.5 % NP-40 ) was added and incubated at
37 °C for 30 min. Then, suspension was obtained by
centrifugation at 4 °C at 1400 rpm for 20 min. The
RNA-protein complex was analyzed by 8 % SDS-
PAGE electrophoresis and transferred to PVDF
membrane. The membrane was cut into two parts.
Part 1 was used for western blotting to confirm the
enrichment of RNA-Ago complex, and part 2 was
used to collect RNA-Ago complex for the construc-
tion of miRNAs-mRNAs library. After western
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blotting with SjAgo antiserum, target band in part 2
was cut and washed with DEPC water. Then, 200 μl
proteinase-K (4 mg/ml) was added and incubated at
37 °C for 20 min, followed by treatment with 200 μl
1xPKL buffer (100 mM Tris-Cl pH 7.5, 50 mM
NaCl, 10 mM EDTA)/7 M urea solution at 37 °C for
20 min. Then, 400 μl phenol and 130 μl chloroform
were added to get rid of the protein. After that,
50 μl NaOAc (pH5.2), 0.75 μl glycogen and 1 ml
mixture of ethanol and isopropanol (1:1) were added
and incubated over night at −20 °C. The next day,
the small RNAs were harvested by centrifugation at
14000 g at 4 °C for 30 min. The dried RNA was dis-
solved in 25 μl DEPC water and was equally divided
into two tubes and stored at 80 °C until use. To con-
firm that the miRNAs and target mRNAs of interest
were successfully pulled down by the Co-IP experi-
ment, PCR was performed with known miRNA
primers and the PCR products were cloned into T-
vector for sequencing analysis. Then, the RNA solu-
tion was ligated with Illumina’s proprietary adaptors,
and the products were amplified by RT-PCR
(TaKaRa, Reverse Transcriptase M-MLV). The puri-
fied PCR products were used for clustering and se-
quencing by an Illumina Genome Analyzer at the
Beijing Genomics Institute, Shenzhen. In this sec-
tion, 200 ng RNA obtained from Co-IP was used for
deep sequencing.
Bioinformatic analysis
All raw data from sequencing were mapped to the S.
japonicum genome to eliminating the possibility of
contamination and to get rid of low quality data.
After that, the length distribution of unique se-
quences was analyzed. To distinguish unique se-
quences originating from rRNA, tRNA, snRNA (small
nuclear RNA) and snoRNA (small nucleolar RNA),
the sequences were compared to sequences of non-
coding RNAs collected in Rfam 9.0 [34, 35] and the
NCBI GenBank data. All rRNAs, tRNAs, snRNAs and
snoRNAs were removed before identification of miR-
NAs and targets sequences [36, 37]. The identification
of S. japonicum miRNAs and target sites were carried
out using previously established criteria [16, 38–40].
Firstly, the precursor sequence of candidate miRNA
can form hairpin-like structure. Secondly, the free en-
ergy of all predicted hairpin-like structures should be
the optimal energy points. Addition to these basic
principles, different algorithms make restriction and
optimization respectively.
To identify the target sequences of miRNA, RNA-
Hybrid was performed with the predicted miRNAs
dataset and the rest of unique data.
Quantitative RT-PCR of miRNAs expression analysis
RNA was extracted from parasites at various stages by
TRIzol method (Invitrogen) according to the manufac-
turer’s instructions. The residual DNA in the RNA prepa-
rations was removed by DNase I treatment. A stem-loop
qRT-PCR method [28] was used to measure the expres-
sion of individual miRNA. cDNA was synthesized using
1 μg total RNA, 50 nM of each stem-loop RT primer,
0.5 mM dNTP, 5 U M-MLV reverse transcriptase (Takara)
and 2 U RNase inhibitor. The program consisted of incu-
bations for 30 min at 16 °C , 30 min at 42 °C, 15 min at
70 °C and then at 4 °C indefinitely. Real-time quantifica-
tion was performed using the Applied Biosystems 7300
Sequence Detection System. The 20 μl PCR reaction in-
cluded 2 μl of cDNA (10:1dilution), SYBR Premix Ex Taq
II (Takara), 0.5 mM specific forward primer and 0.5 mM
common reverse primer. The reactions were run at 95 °C
for 10 s, followed by 40 cycles of 95 °C for 5 s and 60 °C
for 31 s. The 2-△△Ct method was used to calculate the rela-
tive copy numbers of each miRNA with U6 RNA as the
internal standard.
Cell culture and luciferase reportor assays
HEK293T cells were cultured as described previously
[41]. Luciferase reportor assays were developed following
the protocol of the pmirGLO Dual-Luciferase miRNA
Target Expression Vector Report System (Cat: E1330
Promega). Briefly, miRNA duplexes and 2’-O-methyl oli-
gonucleotides mimics (miR-1, miR-21) were chemically
synthesized by Genepharma (Shanghai, China) and used
for the transfection of HEK293T cells after in-vitro an-
nealing. Meanwhile, miRNA target sequences and con-
trol sequences were synthesized and cloned into the
pmirGLO vector through multiple cloning sites located
in the downstream of luciferase (firefly luciferase/renilla
luciferase) gene. Finally, recombinant plasmids were se-
quenced to confirm that the target sequences were
cloned correctly. One hundred and fifty nanograms of
recombinant plasmid and 160 ng miRNA mimic were
co-transfected by X-trene GENE Transfection Reagent
(Roche) in 96-well plates. Luciferase activity was mea-
sured after 24 h using the dual luciferase assay system
(Cat: E1500 Promega).
Results
Generation of anti-SjAgo antibody for HITS-CLIP
A growing body of evidence suggests that SjAgo plays
an important role in the miRNA pathway [20, 22]
and SjAgo1 is the most closely related orthologue to
the ancestral Argonaute known to bind miRNA in
other organisms based on phylogenetic analysis [31].
To investigate the native SjAgo-associated miRNAs
and their potential targets through the HITS-CLIP
assay, a specific antibody against SjAgo was produced
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in the present study. Due to the relatively large mo-
lecular mass of SjAgo1 protein (~109 kDa) which
may lead to difficulty in expressing the whole SjAgo1
protein in prokaryotic expression system, truncation
expression was performed i.e., a fragment of the
SjAgo1 gene (aa 640–946) covering the conserved
PIWI domain among SjAgo1/2/3 was amplified and
cloned into the vector, pET28a (+) (Fig. 1a). A double
enzyme digestion was conducted to confirm that the
target sequence had been inserted. Furthermore, se-
quencing analysis of the inserted gene fragment in
the recombinant plasmid was performed (Fig. 1b).
Next, expression of the recombinant protein rSjAgo
was induced by 0.1 mM IPTG in the BL21 bacterial
strain and purified by affinity purification (Fig. 1c).
Rabbits were subcutaneously immunized with the
purified recombinant protein to generate specific
antibody to SjAgo. ELISA and western blotting exper-
iments showed that the antiserum had high titer and
specificity. The antibody was able to recognize both
recombinant SjAgo1 protein and full-length native
SjAgos including Ago1, Ago2, or Ago3 in total cell
lysate of S.japonicum (Fig. 1d and e).
UV cross-linking and co-immunoprecipitation
To enhance the stability of SjAgo-miRNA-target com-
plex, UV cross-linking was performed before extrac-
tion of total protein. For enrichment of the SjAgo-
miRNA-target complex from total protein, co-
immunoprecipitation [42] was adapted in our study.
As shown in Fig. 2a, SjAgo was successfully pulled
down by co-immunoprecipitation using anti-SjAgo
serum. To avoid false positive reactions, three control
experiments were performed simultaneously. As
Fig. 1 Generation of the anti-SjAgo1 antibody. a Schematic representation of the full-length SjAgo1 protein and the recombinant rSjAgo1 protein
with Hisx6 at the C-terminus as an affinity purification tag. b Restriction enzyme digestion analysis of the recombinant plasmid pET28a (+)-Ago1-
Piwi. Lane 1 is the recombinant plasmid digested with BamH I and Nco I; lane 2 is the control, consisting of the cloned fragment of the SjAgo1
gene. M. DNA ladder. c Coomassie brilliant blue staining of a 12 % SDS-PAGE gel of the total E.coli lysate (1), flow-through (2), and eluted fractions
(3 and 4) from the purification of rSjAgo1 by nickel column chromatography. M. prestained protein ladder. d Western blot assay of rSjAgo1. Lane1
and lane 3 are purified rSjAgo1; Lane 2 and lane 4 are crude E.coli lysate. M. prestained protein ladder. e Western blot assay of total extract of
S.japonicum with anti-SjAgo serum (1) or pre-immune serum (2). The recombinant rSjAgo1 is indicated by an asterisk
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expected, no signal was detected in corresponding po-
sitions in western blots with pre-immune serum con-
trols. However, we do not know whether the miRNAs
and their target sites were enriched simultaneously
with the native SjAgo in this experiment. The prod-
ucts obtained from co-immunoprecipitation were used
for RNA extraction. Then, RT-PCR was performed
using stem-loop primers, which were designed ac-
cording to a few representative known miRNAs of
S.japonicum (see Additional file 1). As shown in
Fig. 2b-d, native SjAgo-associated miRNAs and poten-
tial target mRNAs were successfully enriched and iso-
lated through the co-immunoprecipitation experiment.
Taken together, these results showed that the SjAgo-
miRNA-target complex can be successfully isolated
via UV cross-linking immunoprecipitation with the
specific SjAgo antibody.
High-throughput sequencing and data analysis
Overall, a total of 7,428,407 reads of small RNAs were
generated by SOLEXA sequencing including 596,991
unique contigs. The length of small RNAs ranged from
10 to 65 nt with a peak at 24 nt (Fig. 3a). Further ana-
lysis showed that out of the total small RNA sequences,
899,947 (12 %) come from ribosomal RNA (rRNA),
1,926 (0.025 %) from Small nucleolar RNA (snoRNA),
532,839 (7 %) from transfer RNA (tRNA), 5,427 (0.07 %)
from small nuclear RNA (snRNA), 3,347,983 (45.07 %)
from miRNAs, and 2,640,056 (35.54 %) from mRNAs
(Fig. 3b). The average length of mRNAs in these datasets
are 88 nt (Fig. 3c). Next, the sequences of potential miR-
NAs and mRNAs were clustered as a data set and used
to identify reliable miRNAs and their target sites. As
shown in Table 1 and Additional file 2, compared to
Sanger miRNA database (http://www.mirbase.org/), 513
Fig. 2 Immunoprecipitation of native SjAgo-miRNA-mRNA complex with anti-SjAgo1 antibody. a Western blot assay of immunoprecipitated
SjAgo complex. Lane 1 (control): total parasite extract was directly incubated with Protein A agarose without immune serum; Lane 2
(control): pre-immune serum; Lane 3 (control): only immune serum against SjAgo was incubated with Protein A agarose without total parasite
extract; Lane4: Protein A-agarose was incubated with immune serum against SjAgo in the presence of total parasite extract. The SjAgo complex and
IgG are indicated by asterisks. b RT-PCR products of the small RNAs isolated from the RNA-protein complex after ligation of linkers (17 + 17 nt). cDNA
was synthesized according to the manufacturer’s instructions (TaKaRa), then PCR was performed (35 cycles). The putative miRNA and mRNA
populations were indicated. c and d Verification of four previously identified S.japonicum miRNAs by PCR analysis. c Lanes 1, 4, 7, 10 are
the negative control, lanes 2, 5, 8, 11 are the positive control, and lanes 3, 6, 9, 12 are the experimental groups of cDNAs from Fig. 2b.
d Sequencing of the PCR products amplified from the cDNAs from the SjAgo complex
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putative known miRNAs which have been identified and
released in miRNA-database in all species in previous
study were detected, of which 43 conserved miRNAs
such as miR-1, miR-21, let-7, etc. had been identified in
S.japonicum previously [22, 26, 32]. Interestingly, 256
novel miRNAs (Table 1 and Additional file 3) containing
perfect precursor secondary structure with optimal fold-
ing free energy (see Additional file 4) had been found to
be associated with the native SjAgo. To identify the tar-
get sequences of these miRNAs, RNAHybrid prediction
was performed with the predicted miRNAs data set and
the rest of unique data [43]. Any sequence containing a
region that can match to the seed sequence of a given
miRNA with the lower free energy was considered to be
a candidate target site for this miRNA [38, 44]. The re-
sults showed that a total of 7414 unique sequences were
Fig. 3 Length range and proportion of the small RNAs isolated from the native SjAgo complex. a The isolated small RNAs with a length range
from 10 to 65 nt. b The proportion of various small RNAs determined by the HITS-CLIP assay. c The isolated mRNA with a length range from 57
to 101 nt
Table 1 Analysis of microRNAs and targets found in adult S.japonicum by SOLEXA deep sequencing
Item Putative miRNAs Analysis results** Total targets Average number of targets per miRNA
Known miRNAs 513* 43 7414 ~15
Novel miRNAs 256 256 4440 ~17
*putative miRNAs found in miRBase (http://www.mirbase.org/)
**further bioinformatics analysis of those putative miRNAs with interspecific or intraspecific sequence conservation, precursor secondary structure with optimum
folding free energy, higher abundance, etc
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matched to the “seed” sequences of the 513 putative
known miRNAs, and there were 4440 potential target
sites for the 256 novel miRNAs (see Additional files 5
and 6). This indicates an average of 15 target sites
matched to each native SjAgo-associated miRNA. Thus,
this study was able to establish the SjAgo-associated
miRNA-mRNA interaction network. Nevertheless, all of
these miRNA-mRNA pairings need to be verified by bio-
logical experiments such as luciferase reportor assays [8,
45].
Luciferase reportor assay to validate the potential target
sites
Firstly, we optimized the transfection conditions for
HEK293T cells to yield a maximum incorporation effi-
ciency of miRNAs (see Fig. 4a and Additional file 7:
Table S1). To validate the potential target sites, 6 target
sites of miR-1 were randomly selected and cloned into
pmirGLO vector through MCS located in the 3’UTR of
the luciferase gene. The examined sequences of target
sites and their corresponding mismatch sites were
shown in Additional file 7: Table S2. The mismatch se-
quence was mutated in the target site which matched to
the seed sequence of miRNA-1. Then, miRNA mimics
and recombinant plasmids containing potential target
sites were co-transfected into HEK293T cells to investi-
gate whether the target site was really interacted with
the miRNA. An interaction can lead to reduction in the
expression of the firefly luciferase gene. As shown in
Fig. 4 and Table 2, the activity of firefly luciferase was
significantly reduced in 3 out of 6 miRNA1 groups, indi-
cating that there are multiple target sites of individual
miRNAs. In addition, these data provide a compatible ef-
ficiency (50 %) of target prediction for S.japonicum miR-
NAs by the HITS-CLIP method developed in this study.
Discussion
HITS-CLIP had been successfully used in the identifi-
cation of native Argonaute-associated miRNAs and
their target sites in mouse brain previously [23]. In
that study, the investigators found the positive rate of
predictive targets by Ago-miR-124 was up to 73 %
with 92.5 % specificity. This level of specificity is
much higher than the specificity achieved by using an
analysis of conserved seed sequences alone. In the
present study, approximately 81 % of small RNAs
immunoprecipitated from the SjAgo1-miRNA complex
were miRNAs and mRNAs. miRNAs are recognized
Fig. 4 Verification of the target sites of S.japonicum miRNAs by luciferase reporter assays. a Positive control with different mimic doses suppressed the
activity of the target site. b Verification of partial putative target sites of known miRNA1 found by HITS-CLIP. Data are presented as the mean ± SD of
triplicate independent experiments. “*”: p < 0.05; “**”: p < 0.001 (Student’s t-test)
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as important regulators of gene expression through
specific base-paring with their target mRNAs [10, 18,
46]. A bioinformatic approach, incorporating sequence
matching and mRNA secondary structure to predict
mRNA targets [36, 47, 48], revealed multiple highly
conserved binding sites for miRNAs in the 3’ untrans-
lated region (UTR) [16, 37]. However, luciferase dual-
reportor detection indicated that, as reported by
Sung’s study, some of the miRNAs targets predicted
by bioinformatics were false positives [49–51].
miRNAs, like transcription factors, are an abundant
class of gene-regulatory molecules in animal cells. miR-
NAs regulate a variety of developmental, differentiation
and physiological processes [6, 15, 17, 52]. Most miR-
NAs are expressed in a development- or organ-specific
manner, which provide hints about their functions [8, 9].
It was observed that Ago is essential for mature miRNA
production, thereby it is the primary factor responsible
for the small RNA silencing pathway. Luo et al. analyzed
the expression of SjAgo in different developmental
stages of S. japonicum [31]. The expression pattern of
SjAgo during the life cycle of S. japonicum indicates that
the miRNA regulatory pathway might take part in the
transformation and development of S. japonicum. How-
ever, functional specificities associated with different
Argonautes remain elusive. Wang et al. have reported
that
microRNAs are randomly sorted to individual Argo-
nautes in mammals [53]. In the platyhelminth S. japoni-
cum, miRNAs may take part in a regulatory network
along with transcription factors and growth factors to
control the development and differentiation of the para-
sites [6]. Profiling of miRNA1, miRNA21, miRNAlet-7
expression by stem-loop quantitative RT-PCR revealed
highly stage-specific expression patterns (see Additional
file 8). Importantly, the expression peaks of miRNA1 ap-
peared in schistosomulum, the stage after infection of
the host. These findings indicate that these miRNAs
may be involved in schistosome growth and
development.
The miRNA-71 family is a conserved microRNA
cluster in both S. japonicum and S.mansoni. Xue et
al. cloned the miRNA-71a cluster in adult worm and
analyzed their expression level across the lifespan of
S.japonicum [24, 28]. Subsequently, the same group
demonstrated that miRNA-71a cluster and miRNA-
71b cluster were expressed in schistosomulum, using
deep sequencing and northern blotting. However, in
the present study, only miR71c was found to be asso-
ciated with native SjAgo1 by HITS-CLIP analysis.
There is a possibility that the third S.japonicum Argo-
naute protein, SjAgo3, may also participate in the
processing of miRNA in a complementary pathway,
because both SjAgo1 and SjAgo3 molecules contain
PIWI and PAZ domains [30]. A further HIST-CLIP
assay with antibodies specific to SjAgo3 protein would
give us more information on the different Argonaute-
dependent miRNA pathways controlling gene regula-
tion in various physiological processes in S.
japonicum.
Controlling schistosomiasis remains a huge chal-
lenge in endemic areas, particularly in developing
countries [2, 3], due to little knowledge on S. japoni-
cum physiology. Considering the distinct developmen-
tal stages in vertebrate and invertebrate hosts and the
unique repertoire of genes expressed at different life
cycle stages of the schistosome parasites [6], exploring
the regulatory role of miRNAs in gene expression in-
volved in the parasite’s development, differentiation,
and ability to infect mammalian hosts [4, 6, 54] will
be particularly important for understanding the mech-
anistic details of its physiology and pathogenesis. To
this end, a systematical identification and
characterization of S.japonicum miRNAs and their
target sites by those technique such as Argonaute-
associated HITS-CLIP [23] is the first and essential
step towards understanding the biological regulatory
functions and related mechanisms of miRNAs in
blood flukes [11]. Such identification may enable the
understanding of the biological basis of growth, anti-
genic diversity, infection, and pathogenesis of the
flukes and thereby contribute to the development of
new approaches to prevent and treat schistosomiasis
by providing novel drug targets and vaccine
candidates.
Conclusions
Schistosomes are the responsible pathogens for schisto-
somiasis, which is one of the most prevalent, but
neglected, parasitic diseases in tropical and subtropical
countries. Although some S. japonicum miRNAs have
been discovered in the past decade, a systematic ana-
lysis of miRNAs and their target sites in this parasite
has not been carried out. In the present study, we
have adapted the HITS-CLIP technique to investigate
the native S.japonicum Argonaute proteins (SjAgo)-as-
sociated miRNAs and their target mRNAs by
Table 2 miRNA targets identified by the dual-luciferase
expression vector reportor system
miRNA Target site ID number Validated
miRNA1 T1 T0054493 NO
miRNA1 T2 T0198367 YES
miRNA1 T3 T0090332 YES
miRNA1 T4 T0196767 NO
miRNA1 T5 T0023779 YES
miRNA1 T6 T0149441 NO
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generating a specific antibody against SjAgo. Our data
revealed a total of 769 miRNAs and 11,854 potential
target sites, including 43 known S.japonicum miRNAs.
We demonstrated the efficiency of target prediction
of S.japonicum miRNAs by biological verification
tests. This study not only expands the miRNA
database of S.japonicum but also establishes a SjAgo-
associated miRNA-mRNA interactome, which ad-
vances our understanding of the regulatory network
of gene expression in this pathogen.
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